Drug Discovery and the Market Today Part 4: Developing Amorphous Forms





Dr. David Elder, the Externalization Director for GlaxoSmithKline, talks exclusively to Pharma IQ on his perspective across the industry, including CROs, regulations, and strategising for efficiency.

[eventpdf]

TO READ THE FULL STORY